Stockreport

Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF ALAMEDA, Calif., April 27, 2026 BUSINESS WIRE Infinimmune , a biotechnology company pioneering antibody discovery and design, today announced the appointment of Anthony [Read more]